Status:
COMPLETED
Validation of the PNQ for CIPN Patients.
Lead Sponsor:
Democritus University of Thrace
Conditions:
Chemotherapy-induced Peripheral Neuropathy
Eligibility:
All Genders
18-80 years
Brief Summary
The Patient Neurotoxicity Questionnaire (PNQ) represents a diagnostic tool concerning patients with Chemotherapy Induced Peripheral Neuropathy (CIPN). Application of such a tool in the Greek clinical ...
Eligibility Criteria
Inclusion
- Patients older than 18 and under 80 years of age
- Patients that undergo chemotherapy for the first time
- Patients regardless of cancer type
- Patients regardless of social and education underground
- Patients able to communicate with personnel
Exclusion
- Pediatric patients
- Preexisting neurological condition
- Patients already under chemotherapy treatment
- Patients unable to communicate with personnel
Key Trial Info
Start Date :
April 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04773379
Start Date
April 1 2019
End Date
October 31 2020
Last Update
February 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General Hospital of Rhodes
Rhodes, Dodekanese, Greece, 85133